// App-Quantinova.ai

2304 : Attenuated oncolytic virus HSV1716 increases in vivo expansion of GD2- targeting CAR T cells in murine solid tumor models

Researchers

Presenter

  • Samuel T. Haile

Principal Investigators

  • Joe Conner

  • Crystal Mackall

Medical Centers

  • CCR, NIH, Bethesda, MD

  • Virttu Biologics, United Kingdom.

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Rhabdomyosarcoma

  • Neuroblastoma

  • Osteosarcoma

  • Solid malignancies

  • Melanoma

Biomarkers

  • Cluster of Differentiation 2AP

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin-2

Drug/Treatment

  • HSV1716

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved